Xiaohui Yuan

448 citations
25 papers · 319 indexed · h-index 11
Topics
Pancreatitis Pathology and Treatment (5 papers)Head and Neck Cancer Studies (5 papers)Cancer-related molecular mechanisms research (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Xiaohui Yuan

23 papers receiving 317 citations

Peers

Xiaohui Yuan
Comparison fields: 5 of 61
  • Molecular Biology 178
  • Cancer Research 81
  • Oncology 74
  • Surgery 63
  • Immunology 56
Replace Huayong Zhang with:
Huayong Zhang China
Hongying Zheng China
Chien‐Wei Lee Taiwan
Tetsuro Kawazoe Japan
Ying Luo China
Zhongchao Zhu China
Jo‐Ting Tsai Taiwan
Zhi Zhao China
Xiaohui Yuan relative to Huayong Zhang China Huayong Zhang's profile →
Citations per field
00.5×1.5×2.4×
Huayong Zhang · 1×
Citations per year

Countries citing papers authored by Xiaohui Yuan

Since Specialization
Citations

This map shows the geographic impact of Xiaohui Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohui Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohui Yuan more than expected).

Fields of papers citing papers by Xiaohui Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohui Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohui Yuan. The network helps show where Xiaohui Yuan may publish in the future.

Co-authorship network of co-authors of Xiaohui Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohui Yuan. A scholar is included among the top collaborators of Xiaohui Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohui Yuan. Xiaohui Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 12
4 0
5 8
6 2
7 5
8 13
9 6
10 15
11 30
12 1
13 21
14 15
15 9
16 17
17
Lycorine inhibits tumor growth of human osteosarcoma cells by blocking Wnt/β-catenin, ERK1/2/MAPK and PI3K/AKT signaling pathway.
19
18 2
19 1
20 14

About Xiaohui Yuan

Xiaohui Yuan is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 25 papers that have together received 319 indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (5 papers), Head and Neck Cancer Studies (5 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (81 citations), Otorhinolaryngology (19 citations) and Oncology (74 citations). Xiaohui Yuan has collaborated with scholars based in China and United States. Frequent co-authors include Young E. Whang, Lijun Tang, Qilin Huang, Chi‐Yao Hsueh, Hongli Gong, Hong-Yu Sun, Liang Zhou, Xiaoji Luo, Qiang Huang and Jinyong Luo. Their work appears in journals such as Nature Communications, Applied and Environmental Microbiology and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026